NCT04000035

Brief Summary

Health in work - a measure for increased coping and work participation

  • An effect analysis of a health- and work environment intervention at the workplace. Part 1:quantitative data collection The main objective of this study is to investigate the effect of the workplace intervention in the new Norwegian national programme Health in work (HelseIArbeid) through a pragmatic cluster-randomized study. The main hypothesis is that this interdisciplinary health and welfare intervention at the workplace reduces sick leave and improves mastering of common health problems more efficiently than a conventional welfare intervention. More specifically, it is hypothesized that the Health in work intervention has a better cost-effectiveness in terms of sick leave, use of health services and coping with common health problems indicated by an increased health-related quality of life.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,383

participants targeted

Target at P75+ for not_applicable

Timeline
111mo left

Started Jun 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jun 2019Jul 2035

First Submitted

Initial submission to the registry

June 11, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

June 14, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 27, 2019

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
12 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2035

Expected
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

4 years

First QC Date

June 11, 2019

Last Update Submit

December 10, 2024

Conditions

Keywords

sickness absencepsychosocial work environment

Outcome Measures

Primary Outcomes (4)

  • Change in overall sickness absence rates (self- and physician-certified) at the workplace (unit level)

    Sickness absence data from workplace-registers; Difference-in-difference analyses of sickness absence within and between intervention and control group (% of planned workdays).

    Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

  • Change in healthcare utilization

    Difference-in-difference analyses of health service refunds from National register of control and health service refunds (KUHR database, Helsedirektoratet) and Norwegian Patient Register (NPR, Helsedirektoratet) within and between intervention and control group.

    Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

  • Change in health-related quality of life (HRQoL) by EQ-5D-5L utility value, including EQ-VAS score

    Difference-in-difference analyses of HRQoL within and between intervention and control groups by use of EQ-5D/EQ-VAS.The EuroQol descriptive system EQ-5D-5L describes health along five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Participants rate each dimension along five severity levels from no problems (1) to extreme problems (5).The resulting combination (5 to the power of 5 = 3,125 possible combinations) is attached a utility value based on a national value set on a scale from 1(best health) to a 0(or even lower) for worst health.A Norwegian value set is currently being developed.The EQ-VAS (EuroQol vertical visual analogue scale;0 as worst,100 as best possible score) is an integral part that has to be included when using the EQ-5D questionnaire.It offers important, complementary information on respondents' valuations of their HRQoL that are not necessarily captured by use of the 5 dimensional descriptive part of this instrument.

    Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

  • Health-economic analyses

    Cost-effectiveness analysis based on primary outcome 3 and cost-benefit analyses based on primary outcome 1 and 2. Comparing the intervention arms in terms of incremental costs based on direct- and indirect costs related to interventions throughout the intervention period.

    Time period 24 months prior to randomization through 24 months after randomization

Secondary Outcomes (8)

  • Change in physician-certified sickness absence rates (individual level)

    Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

  • Change in self-certified sickness absence rates (individual level)

    Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

  • Change in psychosocial work environment by Demand-Control-Support-Questionnaire score

    Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

  • Change in social support from colleagues by NDSS-16 score

    Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

  • Change in job satisfaction by GJS score

    Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

  • +3 more secondary outcomes

Study Arms (2)

Health in work

EXPERIMENTAL

The interdisciplinary Health in work intervention consists of three information sessions over the course of one year, with work place processes in between. In the meetings, structured health information about musculoskeletal- and mental disorders is given and put in the context of working and the specific workplace. It is an integrated intervention where information is given together by both healthcare- and NAV-personnel.

Other: Health and work environment information and processes

Regular work place measures

ACTIVE COMPARATOR

Regular work place measures offered by NAV workplace service. Those are interventions given by NAV personnel without healthcare involvement and can be varying.

Other: Health and work environment information and processes

Interventions

see arm/group description

Health in workRegular work place measures

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • minimum 8 employees
  • all staff employed \> 20% in the participating workplaces/workplace units
  • Norwegian-speaking

You may not qualify if:

  • \- ongoing profound reorganisation at the workplace/workplace unit (\>20% change of employees within workplace unit)
  • \- none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Nothern Norway

Tromsø, Norway

Location

Related Publications (2)

  • Hoper AC, Terjesen CL, Fleten N. Comparing the New Interdisciplinary Health in Work Intervention With Conventional Monodisciplinary Welfare Interventions at Norwegian Workplaces: Protocol for a Pragmatic Cluster Randomized Trial. JMIR Res Protoc. 2022 Apr 7;11(4):e36166. doi: 10.2196/36166.

    PMID: 35388792BACKGROUND
  • Terjesen CL, Hoper AC, Farbu EH, Olsen JA, Fleten N. Impact of an intersectoral universal workplace intervention on health related quality of life and wellbeing in a pragmatic cluster randomised trial. Sci Rep. 2025 Jul 29;15(1):27715. doi: 10.1038/s41598-025-12221-1.

MeSH Terms

Conditions

Musculoskeletal Pain

Interventions

Health

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Population Characteristics

Study Officials

  • Nils Fleten, Phd

    UiT The artic University of Norway / Norwegian Welfare Service Troms

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: two groups: intervention and control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 11, 2019

First Posted

June 27, 2019

Study Start

June 14, 2019

Primary Completion

July 1, 2023

Study Completion (Estimated)

July 1, 2035

Last Updated

December 16, 2024

Record last verified: 2024-12

Locations